Pew Comments on Proposals to Modernize Medicare Drug Payments

Some Part D and Advantage changes could reduce costs; others would benefit manufacturers

Pew Comments on Proposals to Modernize Medicare Drug Payments

On Jan. 25, The Pew Charitable Trusts’ drug spending research initiative submitted comments to the Centers for Medicare & Medicaid Services in response to the agency’s proposals to let insurers better manage drug utilization and spending in Medicare’s Part D and Advantage programs.

Pew’s comments supported proposals to expand competition and lower prices, and offered suggestions for additional steps the agency could take to improve savings. Pew also presented an alternative to a proposed formula change that would increase Medicare spending while reducing manufacturers’ contributions to the Part D program, arguing for maximizing these contributions while decreasing beneficiary costs at the pharmacy.

The front facade of the Supreme Court of the United States in Washington, DC.
ian-hutchinson-U8WfiRpsQ7Y-unsplash.jpg_master

Agenda for America

Resources for federal, state, and local decision-makers

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest.

Lightbulbs
Lightbulbs

States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.